EurekAlert! Cancer Research

News Releases

Updates every hour. Last Updated: 4-Nov-2026 19:16 ET (5-Nov-2026 00:16 GMT/UTC)

25-Sep-2026

Treating a deadly brain tumor before it recurs? AI tool may help

University of California - San Francisco
Peer-Reviewed Publication

A new AI-based model can predict where glioblastoma is most likely to return after initial surgery, potentially giving doctors a chance to treat it before it becomes visible on MRI.

Journal: Science Advances

25-Sep-2026

UT MD Anderson shares latest research breakthroughs

University of Texas M. D. Anderson Cancer Center
Peer-Reviewed Publication

Phase 3 results show promise for new immunotherapy advanced lung cancer

Researchers find new role for B7-H3 in cancer immunity and a combination approach that improved outcomes in preclinical models of prostate cancer

Insights suggest which patients are most likely to benefit from CAR T cell therapy and that many patients with appendix cancer could avoid chemotherapy

Blood tests could monitor bone metastases in patients with medullary thyroid cancer

Scientists make advances in detecting risk of and treatment for immunotherapy-related colitis and treatment-induced lung inflammation

25-Sep-2026

Metastatic colorectal cancer is more advanced in younger patients than older ones, but they survive longer with the disease, study finds

American College of Surgeons
Reports and Proceedings

Metastatic colorectal cancer (mCRC) continues to increase in patients aged 45 years or younger, and their longer survival and different disease patterns compared with older patients may warrant more aggressive scrutiny of gastrointestinal symptoms, according to new study findings.

Meeting: American College of Surgeons Clinical Congress 2026

25-Sep-2026

Artificial intelligence model predicts pancreatic cancer risk 3 years before diagnosis

American College of Surgeons
Reports and Proceedings

Researchers at Mayo Clinic have designed an artificial intelligence model that can potentially predict an individual’s risk of developing pancreatic cancer years before diagnosis.

Meeting: American College of Surgeons Clinical Congress 2026

25-Sep-2026

Appendectomy for appendicitis associated with 58% lower colorectal cancer risk than antibiotics alone

American College of Surgeons
Reports and Proceedings

Patients who underwent an appendectomy for acute appendicitis had a significantly lower subsequent risk of colorectal cancer than similar patients treated with antibiotics alone, according to new research.

Meeting: American College of Surgeons Clinical Congress 2026

25-Sep-2026

Prostate cancer surgery and radiation have different long-term effects on urinary, sexual, and survival outcomes

American College of Surgeons
Reports and Proceedings

A national study of more than 20,000 men with prostate cancer compared long-term outcomes after radiation therapy or surgical removal of the prostate, with follow-up of up to 20 years.

25-Sep-2026

Stopping stomach cancer before it starts

Charité - Universitätsmedizin Berlin
Peer-Reviewed Publication

Stomach cancer ranks as one of the deadliest forms of cancer. Unlike many other types of cancer, however, one of its main causes is well known: chronic infections with the bacterium Helicobacter pylori. A team headed by Charité – Universitätsmedizin Berlin has now, for the first time, revealed how such an infection reprograms the stomach lining at the cellular level, thereby paving the way for subsequent cancer. The findings, published in the scientific journal Nature Communications, lay the foundation for preventing the onset of cancer even before a tumor develops. After all, in the best-case scenario, diseases don’t break out in the first place – a goal the researchers are pursuing in collaboration with the ImmunoPreCept Cluster of Excellence.

Journal: Nature Communications

25-Sep-2026

Study identifies two factors that may help patients benefit from off-the-shelf CAR T cell therapies

University of Texas M. D. Anderson Cancer Center
Peer-Reviewed Publication

Researchers at The University of Texas MD Anderson Cancer Center have traced how off-the-shelf chimeric antigen receptor (CAR) T cells behave in patients, revealing how immune rejection and differences among CAR T cells influence their ability to multiply after infusion.

Journal: Cancer Discovery

25-Sep-2026

Momentum: Turning cancer research into patient benefit across Europe

Swedish Cancer Society
Meeting Announcement

European policymakers, researchers, healthcare leaders and patient advocates will gather in Stockholm from 14 to 16 October for Momentum 2026. The conference will examine how Europe can shorten the path from cancer research to patient benefit through stronger collaboration and faster adoption of scientific advances. Speakers include Greg Simon, Joanna Drake, Cary Adams and Elisabete Weiderpass. Journalists are welcome to apply for accreditation.

Funder: International Agency for Research on Cancer (IARC), European Academy of Cancer Sciences (EACS), Rising Tide Foundation for Clinical Cancer Research, Union for International Cancer Control

25-Sep-2026

Dietary supplement may influence lung tumor growth differently in females and males, UCLA study finds

University of California - Los Angeles Health Sciences
Peer-Reviewed Publication

The study highlights the importance of considering biological sex and tumor genetics when developing metabolic approaches to cancer prevention and treatment.

Journal: Cell Reports